2008 DINNER TOPICS/SPEAKERS
|
Kathryn Nattier McFarland, Ph.D. Divisional Vice President, Drug Development Abbott Laboratories, Inc. |
Kathy joined Abbott March 3, 1980 and has held a variety of positions. During her tenure in Chemical Development she led the development, manufacturing, scale-up, and regulatory filings for more than 30 drugs and was named Divisional Vice President in 1999. In particular, she was pivotal in heading up the reformulation task force that successfully addressed Ritonavir Crystal Form 2, continuing to make NORVIR available to AIDS patients around the world. She headed the TriCor (a lipid lowering drug) project team leading to the successful launch of the next generation product in November 2004. As Program Head for Synthroid, she spearheaded a successful strategy integrating technical and commercial elements and culminating in the approval of New Drug Application keeping this key drug available to patients. She became Divisional Vice President of Life Cycle Management in Global Pharmaceutical Research and Development in 2002. In this role she has responsibility to assure that every drug at Abbott has a lifecycle management plan for product improvement incorporated into its business strategy.
Kathy is a member of the Executive Committee for the Abbott women's leadership initiative "Women Leaders in Action." She is Chair of the Development Board of the University of Missouri-Columbia and a member of the Chicago Christian Industrial League Development Board.
Kathy received her Doctor of Philosophy in Physical Organic Chemistry from the University of Missouri-Columbia.